Oramed Pharmaceuticals, Inc. (ORMP)
5.355
+0.14
(+2.78%)
USD |
NASDAQ |
Aug 26, 16:00
5.355
0.00 (0.00%)
After-Hours: 17:42
Oramed Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2025 | -0.85% |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | 92.28% |
| March 31, 2023 | 94.44% |
| December 31, 2022 | 0.00% |
| September 30, 2022 | 0.00% |
| June 30, 2022 | 0.00% |
| March 31, 2022 | 0.00% |
| August 31, 2021 | 0.00% |
| May 31, 2021 | 0.00% |
| February 28, 2021 | 0.00% |
| November 30, 2020 | 0.00% |
| August 31, 2020 | 0.00% |
| Date | Value |
|---|---|
| May 31, 2020 | 0.00% |
| February 29, 2020 | 0.00% |
| November 30, 2019 | 0.00% |
| August 31, 2019 | 0.00% |
| May 31, 2019 | 0.00% |
| February 28, 2019 | 91.74% |
| November 30, 2018 | 94.81% |
| August 31, 2018 | 0.00% |
| May 31, 2018 | |
| February 28, 2018 | 0.00% |
| November 30, 2017 | 0.00% |
| August 31, 2017 | 0.00% |
| May 31, 2017 | 99.68% |
| February 28, 2017 | 0.00% |
| November 30, 2016 | 69.34% |
| August 31, 2016 | -38.81% |
| May 31, 2016 | 0.00% |
| February 29, 2016 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 85.78% |
| Pfizer Inc. | 62.94% |
| Yarrow Bioscience, Inc. | 93.81% |
| Liquidia Corp. | 93.10% |
| NRX Pharmaceuticals, Inc. | 23.43% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 78.30% |
| Return on Assets | 69.54% |
| Return on Invested Capital | 78.02% |
| Return on Net Operating Assets | 13.01K% |